Markets & Investing
Bipartisan Group Pushes Congress for Psychedelic Research
The article Bipartisan Group Pushes Congress for Psychedelic Research was originally published on Microdose.
We write to support language in the Labor,…
The article Bipartisan Group Pushes Congress for Psychedelic Research was originally published on Microdose.
We write to support language in the Labor, Health and Human Services, Education, and Related
Agencies appropriations bill for Fiscal Year 2024 to strongly urge the National Institutes of Health
(NIH) to include active-duty servicemembers in NIH-funded research on psychedelics.As the largest public funder of biomedical research in the world, this directive for the NIH would expand
government wide efforts to understand the potential risks and benefits of psychedelic-assisted therapy to
this critical population.
The opening lines in a letter from members of Congress, pushing for the US government to more aggressively fund research into psychedelic therapy.
This move is being led by a bipartisan group of legislators, including conservative Republicans from red states like Texas. The growing coalition from both left and right shows how psychedelics and their benefits to mental health are a crossover issue both parties can support.
Read the full letter here and a press release from Republican Dan Crenshaw.
psychedelics psychedelic fund research
-
Psychedelics1 week ago
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
-
Law & Regulation1 week ago
FDA to weigh safety, impact of MDMA therapy for PTSD at June meeting
-
Psychedelics1 week ago
MindMed Reports First Quarter 2024 Financial Results and Business Updates
-
Psychedelics1 week ago
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University’s Institute for Psychedelic Research
-
Law & Regulation1 week ago
Compass Pathways keeps plugging away with its psilocybin study trials
-
Psilocybin1 week ago
Oregon authorities give Kaya Holdings license for psilocybin treatment clinic
-
Ketamine1 week ago
Clinical-Stage BioTech Drug Stocks Portfolio UP 7% In w/e May 3rd
-
Psychedelics1 week ago
Optimi Health Provides Corporate Update